Initial Statement of Beneficial Ownership (3)
August 06 2020 - 04:25PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP
OF SECURITIES
|
OMB
APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5 |
|
Filed pursuant to Section 16(a) of the
Securities Exchange Act of 1934 or Section 30(h) of the Investment
Company Act of 1940
|
|
1. Name
and Address of Reporting Person * COUCHMAN
JONATHAN |
2. Date of Event Requiring Statement
(MM/DD/YYYY)
8/3/2020
|
3. Issuer Name and Ticker or Trading
Symbol ENZON PHARMACEUTICALS, INC. [ENZN] |
(Last)
(First)
(Middle)
600 FIFTH AVENUE, 2ND FLOOR |
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)_____
Director ___X___
10% Owner
_____ Officer (give title
below) _____
Other (specify below)
|
(Street)
NEW
YORK, NY 10020
(City)
(State)
(Zip)
|
5. If Amendment, Date Original
Filed(MM/DD/YYYY)
|
6. Individual or Joint/Group
Filing(Check Applicable
Line)___ Form filed by One Reporting
Person
_X_ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially
Owned
|
1.Title of Security
(Instr. 4) |
2. Amount of Securities Beneficially Owned
(Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) |
4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
Common Stock, par value $0.01 per share (1) |
4717666 |
I |
By Jonathan Couchman (2) |
Common Stock, par value $0.01 per share (1) |
400000 |
I |
By Couchman Family Fund (3) |
Common Stock, par value $0.01 per share (1) |
2100524 |
I |
By Xstelos Corp. (4) |
Common Stock, par value $0.01 per share (1) |
633264 |
I |
By Myrexis, Inc. (5) |
Common Stock, par value $0.01 per share (1) |
1667294 |
I |
By Harper Asset Management LLC (6) |
Common Stock, par value $0.01 per share (1) |
0 |
I |
By Michael Pearce (7) |
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible
securities)
|
1. Title of Derivate Security
(Instr. 4) |
2. Date Exercisable and Expiration Date
(MM/DD/YYYY) |
3. Title and Amount of Securities Underlying
Derivative Security
(Instr. 4) |
4. Conversion or Exercise Price of Derivative
Security |
5. Ownership Form of Derivative Security: Direct (D)
or Indirect (I)
(Instr. 5) |
6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Explanation of
Responses: |
(1) |
This Form 3 is filed jointly
by Jonathan Couchman ("Mr. Couchman"), Couchman Family Fund (the
"Foundation"), Xstelos Corp. ("Xstelos") and Myrexis, Inc.
("Myrexis"), Brian Harper, Harper Asset Management, LLC ("HAM"),
and Michael Pearce, (collectively, the "Reporting Persons"). Each
of the Reporting Persons may be deemed to be a member of a Section
13(d) group that collectively owns more than 10% of the Issuer's
outstanding shares of Common Stock (the "Shares"). Each of the
Reporting Persons expressly disclaims beneficial ownership of the
Shares reported herein except to the extent of his or its pecuniary
interest therein, and this report shall not be deemed to be an
admission that any Reporting Person is the beneficial owner of such
Shares for purposes of Section 16 or for any other
purpose. |
(2) |
Represents shares owned
directly by Mr. Couchman. As the sole trustee of the Foundation,
Mr. Couchman may be deemed to beneficially own the Shares owned by
the Foundation. As the Chief Executive Officer of Xstelos, Mr.
Couchman may be deemed to beneficially own the shares of Common
Stock owned by Xstelos. As the Chief Executive Officer of Myrexis,
Mr. Couchman may be deemed to beneficially own Shares of Common
Stock owned by Myrexis. |
(3) |
Represents Shares owned
directly by the Foundation. Mr. Couchman is the sole trustee of the
Foundation. By virtue of this relationship, Mr. Couchman may be
deemed to beneficially own the Shares owned directly by the
Foundation, however he has no pecuniary interest in such
Shares. |
(4) |
Represents Shares owned
directly by Xstelos. Mr. Couchman is the controlling shareholder
and Chief Executive Officer of Xstelos. By virtue of these
relationships, Mr. Couchman may be deemed to beneficially own the
Shares owned directly by Xstelos. Mr. Couchman expressly disclaims
beneficial ownership of such Shares except to the extent of his
pecuniary interest therein. |
(5) |
Represents Shares owned
directly by Myrexis. Mr. Couchman is Chief Executive Officer of
Myrexis. By virtue of this relationship, Mr. Couchman may be deemed
to beneficially own the Shares owned directly by Myrexis. Mr.
Couchman expressly disclaims beneficial ownership of such Shares
except to the extent of his pecuniary interest therein. |
(6) |
Represents shares owned
directly by HAM. Mr. Harper is the President of HAM. By virtue of
this relationship, Mr. Harper may be deemed to beneficially own the
Shares owned directly by HAM. Mr. Harper expressly disclaims
beneficial ownership of such Shares except to the extent of his
pecuniary interest therein. |
(7) |
Represents shares owned
directly by Michael Pearce. Mr. Pearce expressly disclaims
beneficial ownership of such Shares except to the extent of his
pecuniary interest therein. |
Reporting
Owners
|
Reporting Owner Name / Address |
Relationships
|
Director |
10% Owner |
Officer |
Other |
COUCHMAN JONATHAN
600 FIFTH AVENUE
2ND FLOOR
NEW YORK, NY 10020 |
|
X |
|
|
Couchman Family Fund
600 FIFTH AVENUE
2ND FLOOR
NEW YORK, NY 10020 |
|
X |
|
|
Xstelos Corp.
1105 NORTH MARKET STREET
SUITE 1300
WILMINGTON, DE 19801 |
|
X |
|
|
Myrexis, Inc.
600 FIFTH AVENUE
2ND FLOOR
NEW YORK, NY 10020 |
|
X |
|
|
Harper Brian James
2248 MARINER DR.
LONGMONT, CO 80503 |
|
|
|
See explanation of responses |
HARPER ASSET MANAGEMENT LLC
2248 MARINER DR.
LONGMONT, CO 80503 |
|
|
|
See explanation of responses |
Pearce Michael Cooper
193 AUDUBON TRAIL
CASHIERS, NC 28717 |
|
|
|
See explanation of responses |
Signatures
|
/s/ Jonathan Couchman |
|
8/6/2020 |
**Signature of Reporting
Person |
Date |
Couchman Family Fund; By: /s/ Jonathan Couchman,
Trustee |
|
8/6/2020 |
**Signature of Reporting
Person |
Date |
Xstelos Corp.; By: /s/ Jonathan Couchman, Chief
Executive Officer |
|
8/6/2020 |
**Signature of Reporting
Person |
Date |
Myrexis, Inc.; By: /s/ Jonathan Couchman, Chief
Executive Officer |
|
8/6/2020 |
**Signature of Reporting
Person |
Date |
/s/ Jonathan Couchman, attorney-in-fact for Brian
Harper |
|
8/6/2020 |
**Signature of Reporting
Person |
Date |
Harper Asset Management, LLC; By: /s/ Brian
Harper |
|
8/6/2020 |
**Signature of Reporting
Person |
Date |
/s/ Jonathan Couchman, attorney-in-fact for
Michael Pearce |
|
8/6/2020 |
**Signature of Reporting
Person |
Date |